Date Action Amount Person Type
Mar 05, 2024 Sell 77 824 O'neill Gilmore Neil Common Stock
Mar 04, 2024 Sell 20 327 Mei Baisong Common Stock
Mar 02, 2024 Buy 25 966 Lucera Erick Common Stock
Mar 02, 2024 Buy 35 300 Lucera Erick Common Stock
Mar 02, 2024 Buy 106 000 Lucera Erick Stock Option (right to buy)
Mar 02, 2024 Buy 15 055 Burkly Linda Common Stock
Mar 02, 2024 Buy 74 400 Burkly Linda Stock Option (right to buy)
Mar 02, 2024 Buy 24 800 Burkly Linda Common Stock
Mar 02, 2024 Buy 72 212 O'neill Gilmore Neil Common Stock
Mar 02, 2024 Buy 392 100 O'neill Gilmore Neil Stock Option (right to buy)
Mar 02, 2024 Buy 72 213 O'neill Gilmore Neil Common Stock
Mar 02, 2024 Buy 130 700 O'neill Gilmore Neil Common Stock
Mar 02, 2024 Buy 19 457 Mei Baisong Common Stock
Mar 02, 2024 Buy 152 800 Mei Baisong Stock Option (right to buy)
Mar 02, 2024 Buy 19 458 Mei Baisong Common Stock
Mar 02, 2024 Buy 50 900 Mei Baisong Common Stock
Dec 05, 2023 Sell 103 Eaton Bruce Common Stock
Nov 14, 2023 Sell 695 Eaton Bruce Common Stock
Nov 07, 2023 Sell 139 Eaton Bruce Common Stock
Sep 06, 2023 Sell 103 Eaton Bruce Common Stock
Aug 11, 2023 Sell 702 Eaton Bruce Common Stock
Aug 08, 2023 Sell 141 Eaton Bruce Common Stock
Jul 24, 2023 Buy 135 500 Burkly Linda Stock Option (right to buy)
Jul 24, 2023 Buy 45 167 Burkly Linda Common Stock
Jul 24, 2023 Buy 0 Burkly Linda
Jul 19, 2023 Sell 4 317 Mei Baisong Common Stock
Jun 05, 2023 Sell 6 486 O'neill Gilmore Neil Common Stock
Jun 05, 2023 Sell 105 Eaton Bruce Common Stock
Jun 01, 2023 Buy 25 000 Hopfield Jessica Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Connaughton Bernadette Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Reeve Emma Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Vaishnaw Akshay Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Hirsch Andrew Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Scadden David Stock Option (right to buy)
Jun 01, 2023 Buy 25 000 Chatterjee Meeta Stock Option (right to buy)
May 17, 2023 Buy 155 800 Lucera Erick Stock Option (right to buy)
May 17, 2023 Buy 77 900 Lucera Erick Common Stock
May 17, 2023 Buy 0 Lucera Erick
May 11, 2023 Sell 949 Robertson Michelle Common Stock
May 11, 2023 Sell 668 Eaton Bruce Common Stock
May 09, 2023 Sell 135 Eaton Bruce Common Stock
Apr 11, 2023 Buy 50 000 Levy Elliott M. Stock Option (right to buy)
Apr 11, 2023 Buy 0 Levy Elliott M.
Mar 03, 2023 Sell 184 Robertson Michelle Common Stock
Mar 03, 2023 Sell 101 Eaton Bruce Common Stock
Mar 02, 2023 Buy 31 500 Robertson Michelle Common Stock
Mar 02, 2023 Buy 94 500 Robertson Michelle Stock Option (right to buy)
Mar 02, 2023 Buy 18 000 Mei Baisong Common Stock
Mar 02, 2023 Buy 54 000 Mei Baisong Stock Option (right to buy)
Mar 02, 2023 Buy 150 000 O'neill Gilmore Neil Stock Option (right to buy)
Mar 02, 2023 Buy 50 000 O'neill Gilmore Neil Common Stock
Mar 02, 2023 Buy 16 700 Eaton Bruce Common Stock
Mar 02, 2023 Buy 50 000 Eaton Bruce Stock Option (right to buy)
Feb 13, 2023 Sell 2 790 Shearman Mark S Common Stock
Feb 13, 2023 Sell 4 287 Robertson Michelle Common Stock
Feb 13, 2023 Sell 3 307 Eaton Bruce Common Stock
Feb 07, 2023 Sell 346 Eaton Bruce Common Stock
Jan 10, 2023 Sell 1 752 Robertson Michelle Common Stock
Dec 05, 2022 Sell 193 Robertson Michelle Common Stock
Dec 05, 2022 Sell 102 Eaton Bruce Common Stock
Nov 08, 2022 Sell 289 Eaton Bruce Common Stock
Sep 06, 2022 Sell 192 Robertson Michelle Common Stock
Sep 06, 2022 Sell 101 Eaton Bruce Common Stock
Aug 09, 2022 Sell 293 Eaton Bruce Common Stock
Jul 18, 2022 Buy 58 372 Mei Baisong Common Stock
Jul 18, 2022 Buy 0 Mei Baisong
Jun 15, 2022 Sell 5 145 Shearman Mark S Common Stock
Jun 09, 2022 Buy 25 000 Vaishnaw Akshay Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Connaughton Bernadette Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Vaishnaw Akshay Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Reeve Emma Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Reeve Emma Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Scadden David Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Scadden David Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Hopfield Jessica Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Hopfield Jessica Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Chatterjee Meeta Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Chatterjee Meeta Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Hirsch Andrew Stock Option (right to buy)
Jun 09, 2022 Buy 25 000 Hirsch Andrew Stock Option (right to buy)
Jun 03, 2022 Sell 1 123 Eaton Bruce Common Stock
Jun 03, 2022 Sell 1 527 Robertson Michelle Common Stock
Jun 02, 2022 Buy 950 209 O'neill Gilmore Neil Stock Option (right to buy)
Jun 01, 2022 Buy 0 O'neill Gilmore Neil
May 09, 2022 Sell 297 Eaton Bruce Common Stock
Apr 14, 2022 Buy 170 989 Mullen James C Stock Option (right to buy)
Apr 14, 2022 Buy 170 989 Mullen James C Stock Option (right to buy)
Apr 01, 2022 Sell 1 258 Eaton Bruce Common Stock
Mar 03, 2022 Sell 403 Eaton Bruce Common Stock
Mar 03, 2022 Sell 767 Robertson Michelle Common Stock
Feb 10, 2022 Buy 110 732 Eaton Bruce Stock Option (right to buy)
Feb 10, 2022 Buy 37 593 Eaton Bruce Common Stock
Feb 10, 2022 Buy 93 398 Shearman Mark S Stock Option (right to buy)
Feb 10, 2022 Buy 31 709 Shearman Mark S Common Stock
Feb 10, 2022 Buy 157 580 Robertson Michelle Stock Option (right to buy)
Feb 10, 2022 Buy 53 499 Robertson Michelle Common Stock
Feb 08, 2022 Sell 302 Eaton Bruce Common Stock
Jan 11, 2022 Sell 1 744 Robertson Michelle Common Stock
Jan 03, 2022 Sell 18 252 Mullen James C Common Stock
Aug 09, 2021 Sell 287 Eaton Bruce Common Stock
INSIDER POWER
81.818
Last 100 transactions
Buy: 4 455 498 | Sell: 157 736 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 81.818.

In total, the insiders bought 4 455 498 and sold 157 736 EDIT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Editas Medicine, Inc

Editas Medicine Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, whic... EDIT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT